Exelixis | Capitalisation Boursière



Market Capitalization Changement Date
Acadia Pharmaceuticals USD 3.93B 324M 2025-08
Agios Pharmaceuticals USD 2B 66M 2025-08
Amgen USD 160.18B 10.05B 2025-08
AstraZeneca GBP 169.84B 45.67B 2025-08
Bayer EUR 24.85B 240.69M 2025-08
BioMarin Pharmaceutical USD 11.5B 960M 2025-08
Bristol-Myers Squibb USD 90.13B 4.07B 2025-08
Cytokinetics USD 4.16B 214M 2025-08
Eisai JPY 1.22T 15.5B 2025-08
Eli Lilly USD 608.64B 130.15B 2025-08
Exelixis USD 10.64B 1.94B 2025-08
Genmab DKK 91.87B 3.17B 2025-08
Glaxosmithkline USD 76.16B 3.42B 2025-08
Incyte USD 17.01B 3.83B 2025-08
Ionis Pharmaceuticals USD 6.2B 94M 2025-08
MacroGenics USD 204M 3M 2024-12
Merck USD 201.3B 2.52B 2025-08
Moderna USD 10.57B 101M 2025-08
Neurocrine Biosciences USD 12.83B 388M 2025-08
Novartis CHF 189.79B 66.39B 2025-08
Pfizer USD 140.04B 2.51B 2025-08
Sanofi USD 121.02B 3.42B 2025-08
Takeda JPY 6.72T 323.6B 2025-08
Ultragenyx Pharmaceutical USD 2.38B 1.06B 2025-08
Xencor USD 486M 264M 2025-08


Exelixis Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.